West Virginia Code of State Rules › Agency 11 - Medicine › Title 11 - LEGISLATIVE RULE WEST VIRGINIA BOARD OF MEDICINE › Series 11-10 - Practitioner Requirements for Accesing the West Virginia Controlled Substances Monitoring Program Database › Section 11-10-4 - General Rules for Practitioners for Patients Not Suffering from a Terminal Illness

Current through Register Vol. XLI, No. 28, July 12, 2024
4.1. The
				provisions of this section only apply to a practitioner's prescribing,
				administering or dispensing of Schedule II controlled substances, opioids, or
				benzodiazepines to a patient that the practitioner does not consider to be
				suffering from a terminal illness.
4.2 A practitioner shall apply for and
				receive capability to access the CSMP providing a patient any Schedule II
				controlled substance, any opioid, or any benzodiazepine.
4.3. Before initially providing any Schedule
				II controlled substance, any opioid, or any benzodiazepine to a patient a
				current practitioner shall access the CSMP to determine whether the patient has
				obtained any controlled substance reported to the CSMP from any source other
				than the current practitioner within the twelve month period immediately
				preceding the current practitioner's encounter with the patient.
4.4. The practitioner shall promptly document
				the initial CSMP data review in the patient's medical record. Documentation
				must include the date the practitioner accessed the patient's CSMP record, a
				dated copy of the CSMP report or a list of all controlled substances reported
				to the CSMP as dispensed to the patient within the preceding twelve months, and
				the practitioner's rationale for providing the patient Schedule II controlled
				substance(s), opioid(s), and/or benzodiazepine(s).
4.5. If a practitioner-patient relationship
				continues and the course of treatment includes the continued prescribing,
				dispensing or administering of any controlled substance, the practitioner shall
				access the CSMP at least annually to determine whether the patient has obtained
				any controlled substances reported to the CSMP from any source other than the
				current practitioner within the twelve month period immediately preceding the
				date of access. The date of access and any controlled substances from any other
				source other than the current practitioner reported to the CSMP within such
				twelve month period immediately preceding the date of access shall be then
				promptly documented in the patient's medical record by the current
				practitioner, with rationale for continuing provision of the controlled
				substance by the current practitioner.
4.6. A practitioner may review a patient's
				CSMP data more frequently than annually. However, a practitioner must document
				each CSMP data review in the patient medical record. Documentation must include
				the date the practitioner accessed the patient's CSMP record, a dated copy of
				the CSMP report or a list of all controlled substances reported to the CSMP for
				the patient from any source other than the practitioner, and the practitioner's
				rationale for discontinuing or continuing to provide controlled substances to
				the patient.
4.7. A practitioner
				who is providing a patient controlled substance medication shall review a
				patient's CSMP data whenever the provider has a specific concern regarding
				controlled substance abuse, misuse, or diversion of controlled substances by
				the patient.